ICMR approval: India okays use of FDC Kaletra to treat Covid; Hospitalised adult patients with laboratory confirmed SARS CoV-2 infection can give written informed consent to receive the treatment for 14 days.

Presse/Médias

période25 mars 2020

Couverture médiatique

1

Couverture médiatique

  • titreICMR approval: India okays use of FDC Kaletra to treat Covid; Hospitalised adult patients with laboratory confirmed SARS CoV-2 infection can give written informed consent to receive the treatment for 14 days.
    Media name / outletThe Financial Express
    PaysInde
    la date25/03/20
    PersonnesNivedita Gupta